APA

Brussee J. M., Yu H., Krekels E. H. J., de Roos B., Brill M. J. E., van den Anker J. N., Rostami-Hodjegan A., de Wildt S. N. & Knibbe C. A. J. (20190923). First-Pass CYP3A-Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm Neonates. : CPT: pharmacometrics & systems pharmacology.

Chicago

Brussee Janneke M, Yu Huixin, Krekels Elke H J, de Roos Berend, Brill Margreke J E, van den Anker Johannes N, Rostami-Hodjegan Amin, de Wildt Saskia N and Knibbe Catherijne A J. 20190923. First-Pass CYP3A-Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm Neonates. : CPT: pharmacometrics & systems pharmacology.

Harvard

Brussee J. M., Yu H., Krekels E. H. J., de Roos B., Brill M. J. E., van den Anker J. N., Rostami-Hodjegan A., de Wildt S. N. and Knibbe C. A. J. (20190923). First-Pass CYP3A-Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm Neonates. : CPT: pharmacometrics & systems pharmacology.

MLA

Brussee Janneke M, Yu Huixin, Krekels Elke H J, de Roos Berend, Brill Margreke J E, van den Anker Johannes N, Rostami-Hodjegan Amin, de Wildt Saskia N and Knibbe Catherijne A J. First-Pass CYP3A-Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm Neonates. : CPT: pharmacometrics & systems pharmacology. 20190923.